What evaluation and treatment are recommended for a woman with heavy menstrual bleeding who passes large clots?

Heavy Menstrual Bleeding with Large Clots: Evaluation and Treatment

For a woman passing large clots during menstruation, first rule out pregnancy and underlying gynecological pathology (fibroids, polyps, STDs, coagulopathy), then initiate medical management with NSAIDs for 5-7 days or hormonal therapy (combined oral contraceptives or estrogen for 10-20 days), and if this fails or is unacceptable, consider a levonorgestrel-releasing IUD or surgical options 1, 2.

Initial Evaluation

The presence of large clots (≥1 inch diameter), "flooding" (changing pad/tampon more than hourly), or prolonged menses (>7 days) strongly suggests heavy menstrual bleeding and warrants systematic evaluation 3, 4.

Critical First Steps

Rule out pregnancy immediately - all reproductive-age women with abnormal uterine bleeding must have pregnancy testing 5, 6.

Assess hemodynamic stability - check orthostatic blood pressure and pulse. Bleeding that saturates a large pad or tampon hourly for at least 4 hours warrants urgent evaluation 5, 6.

Screen for anemia - obtain hemoglobin and ferritin levels. Low ferritin is both diagnostic and predictive of heavy menstrual bleeding 3, 6.

Identify Underlying Causes

Look specifically for:

• Structural pathology: fibroids, polyps, adenomyosis (consider transvaginal ultrasound) 2, 7
• Bleeding disorders: personal or family history of bleeding, especially if HMB accompanied by prolonged menses or flooding 3, 4, 6
• Ovulatory dysfunction: irregular cycles, PCOS, thyroid disease, hyperprolactinemia 2
• Medications: anticoagulants, antiplatelet agents 5
• STDs and cervical pathology 1

If HMB manifests with flooding and/or prolonged menses, or is accompanied by personal/family bleeding history, refer to hematology for coagulopathy workup 3, 4.

Medical Management

First-Line Treatment Options

NSAIDs (5-7 days during bleeding): Reduces menstrual blood loss through prostaglandin inhibition 1.

Hormonal therapy (10-20 days during bleeding) 1:

• Low-dose combined oral contraceptives (if medically eligible)
• Estrogen therapy (if medically eligible)

These are appropriate for acute management when underlying gynecologic problems have been excluded.

Long-Term Management

Levonorgestrel-releasing IUD (20 μg/day) is the most effective medical approach, achieving 71-95% reduction in menstrual blood loss - comparable to endometrial ablation efficacy 5, 8. This should be strongly considered for ongoing management, particularly in women desiring contraception.

Combined hormonal contraceptives are recommended as first-line maintenance therapy for adolescents and women without contraindications 4, 6, 9.

Cyclic oral progestin reduces bleeding by 87% and can be used when estrogen-containing methods are contraindicated 5, 9.

Important Caveats

• Tranexamic acid and NSAIDs should be avoided in women with cardiovascular disease (particularly those with spontaneous coronary artery dissection) due to MI and thrombosis risk 5
• Hormonal therapy is relatively contraindicated in women with SCAD or significant thrombotic risk factors 5
• If the patient is on anticoagulation, reassess the indication and discontinue if appropriate before initiating other treatments 5

When Medical Management Fails

If bleeding persists despite medical treatment or the woman finds it unacceptable, counsel on alternative methods 1.

Consider surgical options when 2:

• Medical treatment fails, is contraindicated, or not tolerated
• Concomitant significant intracavitary lesions are present
• Patient is clinically unstable despite initial measures

Surgical options include:

• Endometrial ablation (second-generation techniques: thermal balloon, microwave, radiofrequency) - particularly useful when hormones should be avoided 5
• Hysterectomy - definitive treatment reserved for refractory cases 2

Special Populations

Adolescents: Surgery should be reserved for those who don't respond to medical therapy. Combined hormonal contraceptives are first-line, with consideration for adolescent-specific factors in shared decision-making 4, 6.

Women with bleeding disorders: Coordinate care with hematology. Antifibrinolytics (tranexamic acid or aminocaproic acid) in oral or IV form may be used to stop acute bleeding 6.

Women on anticoagulation: First reassess the indication for ongoing antiplatelet/anticoagulant therapy. Consider levonorgestrel IUD as it provides local endometrial effects with minimal systemic absorption 5.